Trial Profile
A Phase II study in adult patients with newly-diagnosed chronic myeloid leukaemia of initial intensified Glivec therapy, and sequential combination therapy for non-responders, in order to assess response and survival
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Jul 2019
Price :
$35
*
At a glance
- Drugs Imatinib (Primary) ; Cytarabine
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- Acronyms TIDEL
- 08 Jun 2016 Status changed from active, no longer recruiting to completed.
- 14 May 2009 New trial record